SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Ascelia Pharma Q3 Operating Loss Narrows After Cost Cuts

Swedish biotech Ascelia Pharma reported a narrower operating loss in Q3 after cost cuts.

SquawkNews Desk 1 updates Updated Nov 05, 2026, 06:45 AM UTC

Story updates

06:45:57 AM UTC
SquawkNews
Sweden's Ascelia Pharma Q3 operating loss narrows after cost cuts

Related stories

Nintendo Sold 24.49M Switch 2 Software Copies in First Half Nintendo sold 24.49 million Switch 2 software copies in the first half, compared with 20.62 million a year earlier. M impact | EQUITY | Nov 05, 2026, 06:55 AM UTC Nintendo Sold 6.49M Switch 2 Consoles in First Half Nintendo sold 6.49 million Switch 2 consoles in the first half, versus 10.36 million a year earlier. M impact | EQUITY | Nov 05, 2026, 06:54 AM UTC KT&G Seeks Share Buyback by 2030 KT&G seeks a share buyback by 2030. M impact | EQUITY | Nov 05, 2026, 06:54 AM UTC Formosa Laboratories Reports October Revenue of NT$497.9M October revenue was NT$497,864,000, compared with NT$401,559,000 a year earlier. January–October revenue totaled NT$4,011,298,000 versus NT$3,948,731,000. M impact | EQUITY | Nov 05, 2026, 06:54 AM UTC Investcorp Closes USD 550 Million Syndicated Term Financing Investcorp closed a USD 550 million syndicated term financing. M impact | EQUITY | Nov 05, 2026, 06:54 AM UTC Commerzbank Q3 Profit and Revenue Rise; FY26 View Backed, NII Outlook Cut Commerzbank reported higher third-quarter profit and revenue, confirmed its fiscal 2026 net profit and revenue outlook, and trimmed its net interest income view, citing increased d M impact | EQUITY | Nov 05, 2026, 06:54 AM UTC